These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25195169)

  • 1. IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers.
    Hernandez ML; Mills K; Almond M; Todoric K; Aleman MM; Zhang H; Zhou H; Peden DB
    J Allergy Clin Immunol; 2015 Feb; 135(2):379-85. PubMed ID: 25195169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma tocopherol-enriched supplement reduces sputum eosinophilia and endotoxin-induced sputum neutrophilia in volunteers with asthma.
    Burbank AJ; Duran CG; Pan Y; Burns P; Jones S; Jiang Q; Yang C; Jenkins S; Wells H; Alexis N; Kesimer M; Bennett WD; Zhou H; Peden DB; Hernandez ML
    J Allergy Clin Immunol; 2018 Apr; 141(4):1231-1238.e1. PubMed ID: 28736267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E, γ-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers.
    Hernandez ML; Wagner JG; Kala A; Mills K; Wells HB; Alexis NE; Lay JC; Jiang Q; Zhang H; Zhou H; Peden DB
    Free Radic Biol Med; 2013 Jul; 60():56-62. PubMed ID: 23402870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects.
    Nightingale JA; Rogers DF; Hart LA; Kharitonov SA; Chung KF; Barnes PJ
    Thorax; 1998 Jul; 53(7):563-71. PubMed ID: 9797755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.
    Janssen O; Schaumann F; Holz O; Lavae-Mokhtari B; Welker L; Winkler C; Biller H; Krug N; Hohlfeld JM
    BMC Pulm Med; 2013 Mar; 13():19. PubMed ID: 23537365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an inhaled endotoxin challenge protocol for characterizing evoked cell surface phenotype and genomic responses of airway cells in allergic individuals.
    Alexis NE; Brickey WJ; Lay JC; Wang Y; Roubey RA; Ting JP; Peden DB
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):206-15. PubMed ID: 18426139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammatory response to inhaled endotoxin does not correlate with airway response.
    Sood AK; Burbank AJ; Lawson M; Zhou H; Wells HB; Peden DB; Hernandez ML
    Respir Res; 2019 Nov; 20(1):252. PubMed ID: 31718667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhaled endotoxin on mucociliary clearance and airway inflammation in mild smokers and nonsmokers.
    Bennett WD; Alexis NE; Almond M; Herbst M; Zeman KL; Peden DB
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):459-65. PubMed ID: 24568613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of the inflammatory response to inhaled endotoxin in healthy volunteers.
    Kobernick AK; Peden DB; Zhou H; Zhou Q; Dillon MA; Alexis NE
    J Allergy Clin Immunol; 2016 Oct; 138(4):1205-1207. PubMed ID: 27297997
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist.
    Leaker BR; Barnes PJ; O'Connor B
    Respir Res; 2013 Dec; 14(1):137. PubMed ID: 24341382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects.
    Singh D; Siew L; Christensen J; Plumb J; Clarke GW; Greenaway S; Perros-Huguet C; Clarke N; Kilty I; Tan L
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1175-84. PubMed ID: 26265232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers.
    Hernandez ML; Herbst M; Lay JC; Alexis NE; Brickey WJ; Ting JP; Zhou H; Peden DB
    J Allergy Clin Immunol; 2012 Oct; 130(4):869-76.e2. PubMed ID: 22770265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway inflammation evaluated in a human nasal lipopolysaccharide challenge model by investigating the effect of a CXCR2 inhibitor.
    Virtala R; Ekman AK; Jansson L; Westin U; Cardell LO
    Clin Exp Allergy; 2012 Apr; 42(4):590-6. PubMed ID: 22192144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative airway inflammatory response of normal volunteers to ozone and lipopolysaccharide challenge.
    Hernandez ML; Harris B; Lay JC; Bromberg PA; Diaz-Sanchez D; Devlin RB; Kleeberger SR; Alexis NE; Peden DB
    Inhal Toxicol; 2010 Jul; 22(8):648-56. PubMed ID: 20540623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.
    Alexis NE; Lay JC; Haczku A; Gong H; Linn W; Hazucha MJ; Harris B; Tal-Singer R; Peden DB
    Environ Health Perspect; 2008 Jun; 116(6):799-805. PubMed ID: 18560537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationship to inhaled endotoxin in normal subjects.
    Michel O; Nagy AM; Schroeven M; Duchateau J; Nève J; Fondu P; Sergysels R
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1157-64. PubMed ID: 9351616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium.
    Schworer SA; Chason KD; Chen G; Chen J; Zhou H; Burbank AJ; Kesic MJ; Hernandez ML
    J Allergy Clin Immunol; 2023 Jun; 151(6):1577-1584.e4. PubMed ID: 36708816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced granulocyte counts in sputum may reflect aggravated disease.
    Persson C; Uller L
    J Allergy Clin Immunol; 2015 Mar; 135(3):836. PubMed ID: 25576079
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune responses of airway neutrophils are impaired in asthma.
    Baines KJ; Simpson JL; Scott RJ; Gibson PG
    Exp Lung Res; 2009 Sep; 35(7):554-69. PubMed ID: 19842845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.
    Lazaar AL; Sweeney LE; MacDonald AJ; Alexis NE; Chen C; Tal-Singer R
    Br J Clin Pharmacol; 2011 Aug; 72(2):282-93. PubMed ID: 21426372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.